Cargando…
Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening
This study sought to identify factors related to the prognosis of intra-abdominal liposarcoma and to determine the optimal minimum duration for remnant tumor screening. Intra-abdominal liposarcoma is associated with high rates of incomplete resection and recurrence requiring a sophisticated follow-u...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571678/ https://www.ncbi.nlm.nih.gov/pubmed/28816941 http://dx.doi.org/10.1097/MD.0000000000007537 |
_version_ | 1783259391157338112 |
---|---|
author | Rhu, Jinsoo Cho, Chan Woo Lee, Kyo Won Park, Hyojun Park, Jae Berm Choi, Yoon-La Kim, Sung Joo |
author_facet | Rhu, Jinsoo Cho, Chan Woo Lee, Kyo Won Park, Hyojun Park, Jae Berm Choi, Yoon-La Kim, Sung Joo |
author_sort | Rhu, Jinsoo |
collection | PubMed |
description | This study sought to identify factors related to the prognosis of intra-abdominal liposarcoma and to determine the optimal minimum duration for remnant tumor screening. Intra-abdominal liposarcoma is associated with high rates of incomplete resection and recurrence requiring a sophisticated follow-up strategy. Patients who underwent surgery for intra-abdominal liposarcoma were included. Cox analyses were used to analyze factors related to recurrence and survival. To determine the optimal minimum duration for remnant tumor screening, patients with recurrence after surgery despite gross complete resection were grouped by a postoperative detection time of 1, 3, or 6 months. Their survivals were compared to the gross incomplete resection group. A total of 168 patients were included. Kaplan–Meier 5-year disease-free survival was 35.9% and overall survival was 66.5%. Multiplicity (HR=2.528, CI=1.585–4.033, P < .001), organ invasion (HR = 1.628, CI = 1.020–2.598, P = .041), and FNCLCC grades (G2,HR = 1.730, CI = 1.000–2.994; G3, HR = 3.812, CI = 2.112–6.880, P < .001) were related to recurrence. Multiplicity (HR = 2.131, CI = 1.050–4.329, P = .036), organ resection ≥3 (HR = 2.857, CI = 1.322–6.174, P = .008), gross incomplete resection (HR = 4.368, CI = 1.890–10.097, P = .001), positive margin (HR = 2.766, CI = 1.367–5.600, P = .005), FNCLCC grade (G2,HR = 2.044, CI = 0.937–4.459; G3,HR = 4.470, CI = 1.893–10.557; P = .003), and RT (HR = 0.322, CI = 0.160–0.648, P = .001) were related to overall survival. Dividing patients into 1 month (P = .097) and 3 months (P = 0.063) did not yield significant differences in univariate analyses, whereas 6 months showed significant difference (P = .015) compared to the gross incomplete resection group. Patients with tumors detected within 6 months showed similar survival to the gross incomplete resection group (HR = 0.552, CI = 0.241–1.260, P = .158), whereas patients with tumor detection after 6 months showed better survival (HR = 0.325, CI = 0.149–0.708, P = .005). In conclusion, minimum duration of 6 months for remnant tumor screening using CT seems optimal. |
format | Online Article Text |
id | pubmed-5571678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-55716782017-09-07 Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening Rhu, Jinsoo Cho, Chan Woo Lee, Kyo Won Park, Hyojun Park, Jae Berm Choi, Yoon-La Kim, Sung Joo Medicine (Baltimore) 5700 This study sought to identify factors related to the prognosis of intra-abdominal liposarcoma and to determine the optimal minimum duration for remnant tumor screening. Intra-abdominal liposarcoma is associated with high rates of incomplete resection and recurrence requiring a sophisticated follow-up strategy. Patients who underwent surgery for intra-abdominal liposarcoma were included. Cox analyses were used to analyze factors related to recurrence and survival. To determine the optimal minimum duration for remnant tumor screening, patients with recurrence after surgery despite gross complete resection were grouped by a postoperative detection time of 1, 3, or 6 months. Their survivals were compared to the gross incomplete resection group. A total of 168 patients were included. Kaplan–Meier 5-year disease-free survival was 35.9% and overall survival was 66.5%. Multiplicity (HR=2.528, CI=1.585–4.033, P < .001), organ invasion (HR = 1.628, CI = 1.020–2.598, P = .041), and FNCLCC grades (G2,HR = 1.730, CI = 1.000–2.994; G3, HR = 3.812, CI = 2.112–6.880, P < .001) were related to recurrence. Multiplicity (HR = 2.131, CI = 1.050–4.329, P = .036), organ resection ≥3 (HR = 2.857, CI = 1.322–6.174, P = .008), gross incomplete resection (HR = 4.368, CI = 1.890–10.097, P = .001), positive margin (HR = 2.766, CI = 1.367–5.600, P = .005), FNCLCC grade (G2,HR = 2.044, CI = 0.937–4.459; G3,HR = 4.470, CI = 1.893–10.557; P = .003), and RT (HR = 0.322, CI = 0.160–0.648, P = .001) were related to overall survival. Dividing patients into 1 month (P = .097) and 3 months (P = 0.063) did not yield significant differences in univariate analyses, whereas 6 months showed significant difference (P = .015) compared to the gross incomplete resection group. Patients with tumors detected within 6 months showed similar survival to the gross incomplete resection group (HR = 0.552, CI = 0.241–1.260, P = .158), whereas patients with tumor detection after 6 months showed better survival (HR = 0.325, CI = 0.149–0.708, P = .005). In conclusion, minimum duration of 6 months for remnant tumor screening using CT seems optimal. Wolters Kluwer Health 2017-08-18 /pmc/articles/PMC5571678/ /pubmed/28816941 http://dx.doi.org/10.1097/MD.0000000000007537 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 5700 Rhu, Jinsoo Cho, Chan Woo Lee, Kyo Won Park, Hyojun Park, Jae Berm Choi, Yoon-La Kim, Sung Joo Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title | Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title_full | Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title_fullStr | Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title_full_unstemmed | Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title_short | Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening |
title_sort | single-center experience with intra-abdominal liposarcoma: optimal minimum duration for postoperative remnant tumor screening |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571678/ https://www.ncbi.nlm.nih.gov/pubmed/28816941 http://dx.doi.org/10.1097/MD.0000000000007537 |
work_keys_str_mv | AT rhujinsoo singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT chochanwoo singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT leekyowon singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT parkhyojun singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT parkjaeberm singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT choiyoonla singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening AT kimsungjoo singlecenterexperiencewithintraabdominalliposarcomaoptimalminimumdurationforpostoperativeremnanttumorscreening |